📰 Haemonetics Co News
Page 2 - Haemonetics Co News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Haemonetics Co. Real-time updates on events, politics, business and more.
January 27, 2024
California Public Employees Retirement System raised its stake in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 53.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 167,782 shares of the medical instruments supplier’s stock after purchasing an additional […]
January 17, 2024
Haemonetics Co. (NYSE:HAE – Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totalling 1,820,000 shares, a growth of 9.0% from the December 15th total of 1,670,000 shares. Based on an average trading volume of 287,500 shares, the short-interest ratio is […]
January 12, 2024
Carmel Capital Partners LLC acquired a new stake in Haemonetics Co. (NYSE:HAE – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The fund acquired 336 shares of the medical instruments supplier’s stock, valued at approximately $30,000. Other hedge funds and other institutional investors have also added to […]
January 1, 2024
Haemonetics Co. (NYSE:HAE – Get Free Report) EVP Michelle L. Basil sold 12,990 shares of Haemonetics stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $88.08, for a total value of $1,144,159.20. Following the sale, the executive vice president now owns 31,257 shares of the company’s stock, […]
January 1, 2024
Haemonetics Co. (NYSE:HAE – Get Free Report) insider Stewart W. Strong sold 8,857 shares of the firm’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $87.53, for a total value of $775,253.21. Following the transaction, the insider now directly owns 18,196 shares in the company, valued […]
December 23, 2023
Cardinal Capital Management lifted its stake in Haemonetics Co. (NYSE:HAE – Free Report) by 2.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,188 shares of the medical instruments supplier’s stock after purchasing an additional 286 shares during the period. Cardinal Capital […]
December 5, 2023
Haemonetics Co. (NYSE:HAE – Get Free Report) was the target of a large increase in short interest during the month of November. As of November 15th, there was short interest totalling 1,800,000 shares, an increase of 7.1% from the October 31st total of 1,680,000 shares. Based on an average daily trading volume, of 276,000 shares, […]
November 18, 2023
Great Lakes Advisors LLC increased its position in shares of Haemonetics Co. (NYSE:HAE – Free Report) by 10.1% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 179,863 shares of the medical instruments supplier’s stock after purchasing an additional 16,569 shares during […]
November 15, 2023
Haemonetics Co. (NYSE:HAE – Get Free Report) saw a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 1,680,000 shares, an increase of 18.3% from the October 15th total of 1,420,000 shares. Currently, 3.4% of the shares of the company are short sold. Based on […]
September 15, 2023
Shares of Haemonetics Co. (NYSE:HAE – Get Free Report) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average […]